American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity

American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity
Published: 2019-03-07

Get a Quote or Let Us Help You!

If you'd like to explore your insurance options, please visit our contact page or connect with a member of The Richards Group team at (262) 326-4750.

Get a Quote Today!

Enjoy this blog? Please spread the word :)

Facebook
LinkedIn
Twitter
Instagram
YouTube
Pinterest
Follow by Email
Google+
http://richardsgroupinsurance.com/feed-items/american-health-packaging-issues-voluntary-nationwide-recall-of-valsartan-tablets-due-to-the-detection-of-ndea-n-nitrosodiethylamine-impurity">
RSS
Follow Us on LinkedIn Follow Us on Twitter Subscribe to Us on YouTube Follow Us on Facebook